CHINESE researchers are working on a possible COVID-19 vaccine and have already started the second phase of human trials.
Continue reading on Express.co.uk
China: It is ‘impossible’ for US to cut ties says ambassador
Research has taken place at the Institute of Medical Biology at the Chinese Academy of Medical Sciences (IMBCAMS). On Sunday, they ensured they were working on efforts to further assess effectiveness and safety. About a dozen vaccines are in different stages of human tests globally, as the World Health Organization warns the coronavirus pandemic is accelerating and “the world is in a new and dangerous phase”.
However, none of the vaccine trials has passed large-scale, late-stage phase 3 clinical trials, a necessary step before getting regulatory approval for sale.
The academy on Sunday started their second phase for their experimental shot, which is among six possible vaccines that scientists in China are testing in humans.
This follows an on-going phase-1 study that has recruited about 200 participants since May, according to the institutes’ social media channels.
The second phase trial will determine the shot’s dose and continue to evaluate whether healthy people will experience immune responses to the vaccine.
IMBCAMS said it expects to use a plant dedicated to producing a coronavirus vaccine this year to prepare for China’s future vaccine supplies
It’s predicted that by the end of 2020, people with special needs will be able to use experimental vaccines under urgent circumstances.
This is according to the director at the Chinese Center for Disease Control and Prevention, Gao Fu.
The coronavirus, which was first detected in China late in 2019, has infected 8.81 million people globally and killed more than 460,000 people.
Chinese officials have also reportedly said the most recent outbreak of the virus in Beijing is down to European strain.
Chinese Center for Disease Control and Prevention (CDC) official Zhang Yong revealed the early research data in an article published by the country’s Central Commission for Discipline Inspection.
“According to preliminary genomic and epidemiological study results, the virus is from Europe, but is different from the virus currently spreading in Europe,” he said.
“It’s older than the virus currently spreading in Europe.”
There has also been growing pressure for China to release public data on the virus sooner rather than later.
This follows criticism over how it handled the initial emergence of COVID-19 in the central city of Wuhan late last year
The country said it has also submitted its latest results to the World Health Organisation (WHO).
The President of the United States, Donald Trump, has attacked the Chinese regime over its’ poor handling of the original outbreak.
He also blames them for moving too slowly and failing to contain the virus.
China has since rejected this claim and said that it published the data as soon as it could.
Following the latest Beijing outbreak, the WHO said last week it had been informed by the Chinese of ongoing investigations into the source of the cluster and the extent of the infections.